FIELD: pharmaceutics.
SUBSTANCE: present invention relates to new methyl-3-aryl-3a-nitro-4-(trifluoromethyl)-1,2,3,3a,4,9b-hexahydrochromeno[3,4-c]pyrrole-1-carboxylateam of general formula I, where: R1 is H, alkoxy C1-C6, Br, Cl; -R2 is H, alkoxy C1-C6, Br, Cl; -Ar is Ph, 4-MeOC6H4, 3,4-(MeO)2C6H3, 2,3,4-(MeO)3C6H2, benzo[d][1,3]dioxol-5-yl, which exhibit cytotoxic activity with respect to human cervical carcinoma cells HeLa, and a method for production thereof.
EFFECT: disclosed is a highly efficient regio- and stereoselective method of producing methyl-3-aryl-3a-nitro-4-(trifluoromethyl)-1,2,3,3a,4,9b-hexahydrochromeno[3,4-c]pyrrole-1-carboxylates, which have cytotoxic activity with respect to human cervical carcinoma cells HeLa and are potential anticancer drugs.
2 cl, 1 dwg, 2 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
3-ARYL-4-(TRIFLUOROMETHYL)-4H-SPIRO[CHROMENO[3,4-C]PYRROLIDINE-1,3'-OXINDOLES] HAVING HIGH CYTOTOXIC ACTIVITY AGAINST HUMAN UTERINE NECK CARCINOMA HeLa CELLS, AND THE METHOD FOR THEIR PREPARATION | 2021 |
|
RU2774705C1 |
6-TRIFLUORO(TRICHLORO)METHYL-SUBSTITUTED SPIRO[CHROMENO[3,4-a]PYRROLIZIDINE-11,3'-INDOLINE]-2'-ONES SHOWING ANTITUMOR ACTIVITY, AND THEIR PRODUCTION METHOD | 2020 |
|
RU2775605C2 |
5-HT RECEPTOR MODULATORS AND METHODS FOR USING THEM | 2010 |
|
RU2542103C2 |
TRICYCLIC PYRROLE DERIVATIVES USEFUL AS 5-HT RECEPTOR MODULATORS | 2010 |
|
RU2567751C2 |
BENZOXAZINE-OXAZOLIDINONE COMPOUND DISPLACED BY A NITROGEN-CONTAINING HETEROCYCLE, METHOD OF SYNTHESIS AND APPLICATION THEREOF | 2018 |
|
RU2744784C1 |
CONDENSED QUINOLINE DERIVATIVE AND USE THEREOF | 2005 |
|
RU2384571C2 |
PENTACYCLIC HETEROCYCLIC COMPOUND | 2020 |
|
RU2815382C2 |
NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR TREATMENT OF MAMMALIAN INFECTIONS AND NEW METABOLIC MECHANISM | 2017 |
|
RU2752568C2 |
AGENT BASED ON ARGLABIN DERIVATIVE, HAVING SELECTIVE CYTOTOXIC ACTION | 2023 |
|
RU2814738C1 |
PYRROLOCHINOLINE DERIVATIVES AS 5-HT ANTAGONISTS, METHODS FOR PRODUCTION THEREOF AND USE | 2013 |
|
RU2688161C2 |
Authors
Dates
2024-04-25—Published
2023-02-10—Filed